Status:
COMPLETED
Contrast RISK (Reducing Injury Sustained by Kidneys)
Lead Sponsor:
University of Calgary
Collaborating Sponsors:
Alberta Innovates Health Solutions
Alberta Health services
Conditions:
Acute Kidney Injury (Nontraumatic)
Coronary Artery Disease
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Diagnostic and therapeutic cardiac catheterization procedures are important interventions to reduce the risk of death, avoid future cardiovascular events, and improve quality of life of people with he...
Detailed Description
Overview: Randomized stepped-wedge trial to evaluate the impact of implementing a computerized decision support strategy that incorporates CI-AKI risk prediction and calculation of safe contrast dye l...
Eligibility Criteria
Inclusion
- Adult patients undergoing diagnostic coronary angiography or coronary intervention in Alberta
Exclusion
- Emergency primary percutaneous coronary intervention for ST-elevation myocardial infarction
- Receiving dialysis at time of cardiac catheterization procedure
- Non-Alberta resident
Key Trial Info
Start Date :
January 22 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2020
Estimated Enrollment :
7280 Patients enrolled
Trial Details
Trial ID
NCT03453996
Start Date
January 22 2018
End Date
November 1 2020
Last Update
November 28 2023
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Foothills Medical Centre
Calgary, Alberta, Canada
2
Royal Alexandra Hospital
Edmonton, Alberta, Canada
3
University of Alberta Hospital
Edmonton, Alberta, Canada